4AB:FRA
AbbVie Common Stock
€261.00
arrow_downward
-1.21%(-3.20) 1D
Nov 2, 11:28:47 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€260.50
High
€261.00
Low
€260.50
Mkt. cap
521.11B
Avg. vol.
101.00
Volume
28.00
52-wk high
€261.00
52-wk low
€167.55
No. of employees
57K
Open
€260.50
High
€261.00
Low
€260.50
Mkt. cap
521.11B
Avg. vol.
101.00
Volume
28.00
52-wk high
€261.00
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo
Investing.com
·
2 hours ago
Wells Fargo raises Abbvie stock price target to $340 on pipeline
The Globe and Mail
·
1 day ago
The top 5 analyst questions from AbbVie’s Q3 earnings call
The Motley Fool
·
1 day ago
Is AbbVie a Buy After Its Latest Earnings Report?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com